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A new, civil day!
Recently the news has been filled 
with examples of incivility and lack 
of professionalism. In Congress the 
representative from South Carolina shouted, 
“You lie!” to President Obama. The final 
matches of this year’s U.S. Open tennis 
tournament were marred by inappropriate 
behavior, both on the women’s and men’s 
side. At a recent national awards telecast, 
Kanye West interrupted the presentation to 
the winner, Taylor Swift. Is civility dead?
Surveys of health care workers have pointed 
out that incivility, and disruptive physician 
behaviors, occur commonly. The resulting 
hostile environment erodes cooperation and 
commitment to high quality care. The Joint 
Commission has asked hospitals to develop 
formal and consistent ways of addressing 
disruptive behavior. There are articles 
in recent medical professional journals 
encouraging us to be intolerant of disruptive 
physician behavior.  
Recently, Dr. John Moore brought to my 
attention the fact that the Thomas Jefferson 
University (TJU) Code of Conduct, and its 
accompanying Honor Code, had not been 
put in place for our faculty, but was in effect 
for our medical students. I am pleased 
to report that the Department of Surgery 
unanimously approved the TJU Code of 
Conduct and Honor Code and implemented 
it as a departmental policy.  
We feel strongly that disruptive behavior, 
incivility, and unprofessional behavior, 
should not be tolerated. We recognize that 
faculty behaviors influence others, and we 
wish to serve as positive role models. We 
condone neither horizontal violence nor 
vertical violence, and recognize the impact 
of such behaviors on physical aspects of 
living, self-esteem, and self-confidence. 
My thanks go to Dr. Moore and the 
faculty, residents, fellows, and staff of our 
department. We have embarked upon a new 
day. A new civil day!
A mandate in spring of 2009 by the 
Centers for Medicare & Medicaid 
Services (CMS) ruled that only CMS-
certified centers would be eligible 
for reimbursement under Medicare 
for Ventricular Assist Device (VAD) 
implantation. The CMS visited in July, 
and Jefferson was accredited as of  
August 11, 2009. 
“This ensures that we are able to offer 
our first-rate care to the widest possible 
patient population,” says Director of the 
Mechanical Circulatory Support Program 
Scott Silvestry, MD, “which is critical to our 
mission as an academic medical center.”
During the CMS two-day visit, the auditor 
had what Dr. Silvestry describes as “an 
extremely favorable impression of the 
multidisciplinary and collaborative spirit 
between the surgical and medical teams.” 
VAD Coordinator Barbara Ebert, CRNP, 
is instrumental in managing care and 
assuring consistency across the entire 
process. “These patients are extremely 
labor-intensive for caregivers—even more 
so after the LVAD implant,” Dr. Silvestry 
notes. “They require constant monitoring 
and evaluation.  Multidisciplinary 
collaborative care is essential to good 
outcomes for all of our patients.” He 
adds that the Departments of Pharmacy, 
Physical and Occupational Therapy, 
and Nursing, as well as students and 
fellows, have been active collaborators, 
from the organ harvest process, to 
echocardiograms, to post-operative care 
in the Intensive Care Unit (ICU) and 
Heart Failure Unit (at 5 West in the 
Gibbon Building).
VAD technology shows a significant and 
sustainable benefit for patients with heart 
failure who are not candidates for a heart 
Ventricular Assist Device 
Program Gains Prestigious 
Accreditation
Program Director, Scott Silvestry, MD, along with Drs. Linda Bogar, Hitoshe Hirose, and 
Michel Haddad (not shown) comprise the surgical component of Jefferson’s Mechanical 
Circulatory Support Program.
Overview Clinical Integration
MEET OUR  
SURGICAL INTERNS
Jefferson surgeons are currently 
assisted by an exceptional group 
of categorical interns, half of 
them Jefferson Medical College 
graduates. These doctors, who 
recently matched with Jefferson, 
started on June 20, 2009 (l to r):
Katrina Harper, MD  
Georgetown University
Kathleen Lamb, MD  
Jefferson Medical College
Carrie Houssock, MD 
Jefferson Medical College
Jose Munoz, MD 
UMDNJ/New Jersey Medical School
Renee Tholey, MD 
Jefferson Medical College
Konrad Sarosiek, MD 
Drexel University
Please Welcome
Dr. Houssock, who was a preliminary intern last 
year, is now joining the PGY2 class. We are also 
pleased to welcome back another Jefferson 
Medical College graduate, Erika Davis, MD, as a 
preliminary intern in General Surgery. 
transplant. “The reality is that few patients 
are eligible for transplants,” Dr. Silvestry 
says. For some patients who are candidates, 
the wait time may exceed 200 days. “VADs, 
including experimental therapies such as 
the Jarvik Heart, can get them through this 
potentially long wait to transplant. 
Under the leadership of James Diehl, MD, 
Director of the Cardiothoracic Surgery 
Division, the Cardiac Surgery Program as 
a whole has expanded greatly over the last 
six years and recruited several excellent 
surgeons. Linda Bogar, MD, who was 
recruited five years ago, has now taken 
on a more senior role, which includes 
mentoring the more junior surgeons as 
well as performing a number of heart 
transplants and VAD procedures on 
her own. Benjamin Youdelman, MD, 
has now been on staff for two years. His 
practice, based primarily at Einstein 
Hospital, specializes in endovascular and 
thoracic aortic surgery, valve repair and 
replacement. Michel Haddad, MD, who 
joined Jefferson in 2008, is acting Director 
of the Surgical Cardiac Care Unit. With 
a wealth of experience in intensive care 
of cardiac surgery patients, Dr. Haddad 
splits his time between the operating room 
and the ICU. Finally, Hitoshi Hirose, 
MD, who recently completed fellowships 
at Hahnemann and Jefferson, joined the 
faculty last August which further increases 
the program’s capacity to care for complex 
cardiac patients.
New Cancer Research Angle  
from a Surprising Source
In medical research—like in all areas of 
innovation—it is impossible to predict 
where the next great idea might come 
from. The Department of Surgery recently 
hosted a researcher who is investigating 
an unusual potential cancer treatment: 
Anthony Holland, PhD, a renowned 
composer who has conducted at Carnegie 
Hall and has been teaching at Skidmore 
College for 27 years. 
Since early in his career, Dr. Holland has 
been interested in physics and acoustics. 
“Years ago I read a book [about] a 
frequency machine that was capable 
of destroying microorganisms if it was 
tuned to just the right frequency.” This 
made sense intuitively to Dr. Holland; 
each semester he taught his students 
to be careful about conditions that can 
create sound that travels at a particular 
wavelength, which can develop a 
“resonant frequency.”
Dr. Holland had audited courses on 
microbiology in the past. “I learned to use 
microscopes and to grow and safely keep 
bacteria—and later cancer cells—in an 
incubator.” Dr. Holland was able to gather 
the necessary electronic components 
and build a frequency machine. For 
fifteen months he ran test frequencies on 
harmless, easy-to-obtain microorganisms 
(paramecium and blepharisma). 
“I began to try different frequencies, and 
at first nothing happened. Then I tried 
putting more than one frequency into 
the organism simultaneously.” Then 
a light bulb went on for Dr. Holland. 
“If I added one additional frequency, 
in a special relationship to the first 
frequency, I’d be creating more power 
and have a better chance at landing on 
the frequency necessary to change the 
organism,” Dr. Holland says. “When I 
added the eleventh harmonic, I looked 
through the microscope and discovered 
that the microorganism had shattered. 
It reminded me of how a crystal glass 
shatters when a soprano hits just the  
right note.” 
As luck would have it, in 2008, Dr. 
Holland attended a Skidmore Alumni 
Day presentation on pancreatic cancer 
by his former student Jonathan Brody, 
PhD, Assistant Professor in Jefferson’s 
Division of Surgical Research. Following 
the presentation, Dr. Holland invited him 
to watch his video of the cells exploding. 
After several minutes, Dr. Brody asked, 
“Could you blow up cancer cells like 
that?” Dr. Holland said, “I don’t know, 
but I’d like to try.” Dr. Brody then 
arranged Dr. Holland’s mini-sabbatical in 
the Department of Surgery at Jefferson. 
“Jefferson has been extremely open-
minded throughout this process, 
which is the ultimate test of a research 
institution,” says Dr. Holland. “I assumed 
that physicians and other researchers 
would think it was a nutty idea,” he 
confesses. “But to the contrary—everyone 
I encountered realized the potential. I 
have never experienced such a wonderful 
reception of new ideas in my entire 
professional life.” 
“Dr. Holland is an extraordinary man,” 
says Dr. Brody, who has been impressed 
by his work since he was his student in 
the 1990s. “and we need extraordinary 
people working together from many 
angles to fight this devastating disease.” 
Preliminary results suggest that Dr. 
Holland’s device causes changes in the 
size and shape of pancreatic cancer cells. 
“This reflects that we’re in the right 
ballpark,” he says, “that the frequency 
could affect cells as to destroy them.” Dr. 
Holland was invited back to Jefferson in 
August to repeat two key experiments, 
and he reports that highly technical 
quantitative analysis indicates some 
promising results. 
Dr. Holland is going on sabbatical from 
Skidmore this January, and plans to 
continue (and ultimately publish) his 
research. “When people ask me what 
kind of music I’m composing now,” he 
says, “I tell them I’m writing music for 
microorganisms and cancer cells. But 
what makes this piece different, is that if 
I do it right, it won’t be enjoyable to the 
audience. It will do them in.”
Sharon Molotsky, RN,  
BSN, CCRC
Clinical Research Nurse Project Manager
How long have you been at Jefferson?
I’ve been here off and on since 1997,  
first in the Department of Radiology. In 
the interim I worked at Temple University 
Hospital and Shriners Hospital for Children. 
I’ve been in my current position since  
March 2009, but previously served as the 
research coordinator for the Division of 
Vascular and Endovascular Surgery. 
What are the responsibilities of your 
current role?
I coordinate clinical trials for the Department 
of Surgery and handle the administration 
of Institutional Review Board submissions 
and budgets for industry trials. My primary 
responsibility is to provide support to the 
faculty who are undertaking an increasing 
number of clinical research projects in their 
efforts to establish a more robust clinical 
trial program in the department.
What is required to become certified as a 
Clinical Research Coordinator?
The formal Certified Clinical Research 
Coordinator (CCRC) certification by 
the Association of Clinical Research 
Professionals requires experience in 
clinical practice, knowledge of Food and 
Drug Administration (FDA) regulations, 
a comprehensive written exam, and 
continuing education in clinical research  
as well as nursing. 
What does an average day  
on the job look like?
It really varies almost daily. One day,  
I might recruit patients to participate in  
a particular study. In early August,  
I supervised a study monitor’s four-day  
visit for one of our ongoing industry-
sponsored trials. I also evaluate new studies 
proposed to our surgeons to determine 
their fiscal feasibility, if they are ethically 
appropriate and whether we have the 
appropriate patient population. Given the 
range of responsibilities I’m juggling, a 
critical part of my job is time management!
Anthony Holland, PhD, composer and professor, conducting radiofrequency experiments on 
pancreatic cancer cells in a Division of Surgical Research laboratory at Jefferson
For an appointment with a Jefferson Surgeon, call 1-800-JEFF-NOW
Changing Lives Through Research On the Job
Jefferson has been 
extremely open-minded 
throughout this process, 
which is the ultimate test 
of a research institution
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